These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 23892588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
    Leung R, Lang B, Wong H, Chiu J, Yat WK, Shek T, Cho WY, Yau LC, Yau T.
    Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of mTOR in carcinoid tumors.
    Grozinsky-Glasberg S, Pavel M.
    Target Oncol; 2012 Sep; 7(3):189-95. PubMed ID: 22886906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
    Pivonello C, Rousaki P, Negri M, Sarnataro M, Napolitano M, Marino FZ, Patalano R, De Martino MC, Sciammarella C, Faggiano A, Rocco G, Franco R, Kaltsas GA, Colao A, Pivonello R.
    Endocrine; 2017 Jun; 56(3):603-620. PubMed ID: 27688013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Carcinoid tumors].
    Pregun I, Bodoky G, Rácz K, Tulassay Z.
    Orv Hetil; 2010 Nov 14; 151(46):1885-94. PubMed ID: 21044939
    [Abstract] [Full Text] [Related]

  • 14. Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors.
    Narayanan S, Kunz PL.
    Hematol Oncol Clin North Am; 2016 Feb 14; 30(1):163-77. PubMed ID: 26614375
    [Abstract] [Full Text] [Related]

  • 15. [Chemoembolization, immunotherapy and hormone therapy of carcinoid and digestive neuroendocrine tumors].
    Gouyon B, Ruszniewski P.
    Ann Gastroenterol Hepatol (Paris); 1995 Feb 14; 31(2):121-3. PubMed ID: 7618834
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.